Market Overview

Alexion Recommends Rejection of $90.50/Share Mini-Tender Offer by TRC Capital

Alexion Pharmaceuticals. (NASDAQ: ALXN) has been notified of an
unsolicited "mini-tender" offer by TRC Capital Corporation to purchase
up to 1.5 million shares, or approximately 0.77%, of the outstanding
Alexion common stock at a price of $90.50 per share. TRC's offer price
represents approximately a 5.06% discount to the closing price of
Alexion common stock on February 5, 2013, the last closing price on the
day prior to the date of the offer. In addition, TRC's offer is subject
to numerous conditions.

Alexion does not endorse TRC's offer and recommends that shareholders
reject the offer and do not tender their shares. This offer is a
so-called "mini-tender" offer at a price below the current market price

See full press release

Posted-In: News Guidance Contracts Management M&A Global

 

Related Articles (ALXN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters